Biocomposites Release: Independent Study Confirms Superior Properties of ZPC(TM) Enhanced Calcium Composite Bone Grafts

Published: Jul 27, 2009

KEELE, England, July 27 /PRNewswire/ -- A recent independent study has confirmed Fortoss VitalĀ®, developed by the Pioneering Orthobiologics Company, Biocomposites, (, as an effective bone replacement material demonstrating superior bone regenerative properties due to its unique negative zeta potential control (ZPC(TM)).

Back to news